Search

Search Constraints

You searched for: Author/Creator Wang, C-C

Search Results

3. 474O Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC. (24th November 2019)

6. Annualized clinical event rates during two-year follow-up are low in 27, 617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program. (24th May 2021)